Literature DB >> 22946725

Complex single gene disorders and epilepsy.

Aine Merwick1, Margaret O'Brien, Norman Delanty.   

Abstract

Epilepsy is a heterogeneous group of disorders, often associated with significant comorbidity, such as intellectual disability and skin disorder. The genetic underpinnings of many epilepsies are still being elucidated, and we expect further advances over the coming 5 years, as genetic technology improves and prices fall for whole exome and whole genome sequencing. At present, there are several well-characterized complex epilepsies associated with single gene disorders; we review some of these here. They include well-recognized syndromes such as tuberous sclerosis complex, epilepsy associated with Rett syndrome, some of the progressive myoclonic epilepsies, and novel disorders such as epilepsy associated with mutations in the PCDH 19 gene. These disorders are important in informing genetic testing to confirm a diagnosis and to permit better understanding of the variability in phenotype-genotype correlation. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22946725     DOI: 10.1111/j.1528-1167.2012.03617.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  Phelan-McDermid syndrome presenting with autistic spectrum: are we underdiagnosing chromosomal diseases in patients with autism?

Authors:  Wladimir Bocca Vieira de Rezende Pinto; José Luiz Pedroso; Paulo Victor Sgobbi de Souza; Acary Souza Bulle Oliveira; Orlando Graziani Povoas Barsottini
Journal:  J Neurol       Date:  2013-09-29       Impact factor: 4.849

Review 2.  Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies.

Authors:  Jing-Qiong Kang
Journal:  Epilepsy Res       Date:  2017-08-26       Impact factor: 3.045

Review 3.  Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.

Authors:  Jing-Qiong Kang; Robert L Macdonald
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

Review 4.  How might novel technologies such as optogenetics lead to better treatments in epilepsy?

Authors:  Esther Krook-Magnuson; Marco Ledri; Ivan Soltesz; Merab Kokaia
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  PCDH19-Related Epilepsy in Early Onset of Chinese Male Patient: Case Report and Literature Review.

Authors:  Xiao Yang; Jing Chen; BiXia Zheng; Xianyu Liu; Zixuan Cao; Xiaoyu Wang
Journal:  Front Neurol       Date:  2020-04-30       Impact factor: 4.003

6.  Electroacupuncture-induced attenuation of experimental epilepsy: a comparative evaluation of acupoints and stimulation parameters.

Authors:  Xuezhi Kang; Xueyong Shen; Ying Xia
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-26       Impact factor: 2.629

7.  Increased Blood-Reelin-Levels in First Episode Schizophrenia.

Authors:  Tobias Hornig; Carola Haas; Lukas Sturm; Bernd Fiebich; Ludger Tebartz van Elst
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

8.  Late-onset Lafora disease with prominent parkinsonism due to a rare mutation in EPM2A.

Authors:  David S Lynch; Nicholas W Wood; Henry Houlden
Journal:  Neurol Genet       Date:  2016-08-16

9.  Correction of a Splicing Mutation Affecting an Unverricht-Lundborg Disease Patient by Antisense Therapy.

Authors:  Liliana Matos; Ana Joana Duarte; Diogo Ribeiro; João Chaves; Olga Amaral; Sandra Alves
Journal:  Genes (Basel)       Date:  2018-09-11       Impact factor: 4.096

Review 10.  Classifying epilepsy pragmatically: Past, present, and future.

Authors:  Nathan A Shlobin; Gagandeep Singh; Charles R Newton; Josemir W Sander
Journal:  J Neurol Sci       Date:  2021-05-29       Impact factor: 4.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.